These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31285178)

  • 41. Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?
    Remon J; Besse B; Soria JC
    BMC Med; 2017 Mar; 15(1):55. PubMed ID: 28285592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. First-line Pembrolizumab Versus Pembrolizumab Plus Chemotherapy Versus Chemotherapy Alone in Non-small-cell Lung Cancer: A Systematic Review and Network Meta-analysis.
    Kim R; Keam B; Hahn S; Ock CY; Kim M; Kim TM; Kim DW; Heo DS
    Clin Lung Cancer; 2019 Sep; 20(5):331-338.e4. PubMed ID: 31164319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The metastatic site does not influence PD-L1 expression in advanced non-small cell lung carcinoma.
    Wang H; Agulnik J; Kasymjanova G; Fiset PO; Camilleri-Broet S; Redpath M; Cohen V; Small D; Pepe C; Sakr L; Spatz A
    Lung Cancer; 2019 Jun; 132():36-38. PubMed ID: 31097091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Continuous pemetrexed treatment for brain metastasis in non-small cell lung cancer--a report of two cases.
    Ochi N; Yamane H; Yamagishi T; Takigawa N
    Lung Cancer; 2013 Apr; 80(1):111-3. PubMed ID: 23279874
    [No Abstract]   [Full Text] [Related]  

  • 45. Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
    Reck M; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Leiby MA; Lubiniecki GM; Shentu Y; Rangwala R; Brahmer JR;
    N Engl J Med; 2016 Nov; 375(19):1823-1833. PubMed ID: 27718847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Not Available].
    Evers G; Mohr M; Kerkhoff A; Lenz G; Wiewrodt R; Schmidt LH
    Dtsch Med Wochenschr; 2017 Oct; 142(20):1531-1534. PubMed ID: 29017211
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retreatment with pembrolizumab in advanced non-small cell lung cancer patients previously treated with nivolumab: emerging reports of 12 cases.
    Fujita K; Uchida N; Kanai O; Okamura M; Nakatani K; Mio T
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):1105-1109. PubMed ID: 29675747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC).
    Raez LE; Santos ES; Webb RT; Wade J; Brito RA; Karr M; Kennah A; Childs BH
    Cancer Chemother Pharmacol; 2013 Nov; 72(5):1103-10. PubMed ID: 24057043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Erlotinib and nonsmall cell lung cancer with brain metastases: a case study with a complete and prolonged response over 17 months].
    Mairovitz A; Staub E; Le Floch H; Rivière F; Bonnichon A; Margery J; Vaylet F
    Rev Pneumol Clin; 2009 Oct; 65(5):318-21. PubMed ID: 19878809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Real-World Experience With Pembrolizumab in Patients With Advanced Lung Cancer.
    Peng TR; Wu TW
    Am J Ther; 2019; 26(4):e537-e538. PubMed ID: 30946046
    [No Abstract]   [Full Text] [Related]  

  • 51. Bevacizumab in Patients with Nonsquamous Non-Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study.
    Besse B; Le Moulec S; Mazières J; Senellart H; Barlesi F; Chouaid C; Dansin E; Bérard H; Falchero L; Gervais R; Robinet G; Ruppert AM; Schott R; Léna H; Clément-Duchêne C; Quantin X; Souquet PJ; Trédaniel J; Moro-Sibilot D; Pérol M; Madroszyk AC; Soria JC
    Clin Cancer Res; 2015 Apr; 21(8):1896-903. PubMed ID: 25614446
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brain metastasis responding to gefitinib alone.
    Poon AN; Ho SS; Yeo W; Mok TS
    Oncology; 2004; 67(2):174-8. PubMed ID: 15539923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pembrolizumab for choroidal metastases from non-small cell lung cancer: a case report and literature review.
    Li X; Liang Y; Wang J; Hu Z; Yuan ZL; Xie P
    Hum Vaccin Immunother; 2021 Aug; 17(8):2626-2629. PubMed ID: 33769211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinical utility of PD-L1 testing in selecting non-small cell lung cancer patients for PD1/PD-L1-directed therapy.
    Villaruz LC; Socinski MA
    Clin Pharmacol Ther; 2016 Sep; 100(3):212-4. PubMed ID: 27090296
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prolonged response with paclitaxel after immunotherapy by pembrolizumab in lung cancer].
    Zapata E; Mennecier B; Leduc C; Chatron E; Quoix E
    Rev Pneumol Clin; 2016 Oct; 72(5):300-304. PubMed ID: 27561974
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ongoing trials with bevacizumab and other antiangiogenic agents in lung cancer.
    Dowlati A
    Clin Lung Cancer; 2008 Mar; 9 Suppl 2():S71-5. PubMed ID: 21885002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Not Available].
    Fabre E; Pécuchet N; Cadranel J
    Bull Cancer; 2016 Nov; 103 Suppl 1():S138-S143. PubMed ID: 28057177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
    Gandhi L; Rodríguez-Abreu D; Gadgeel S; Esteban E; Felip E; De Angelis F; Domine M; Clingan P; Hochmair MJ; Powell SF; Cheng SY; Bischoff HG; Peled N; Grossi F; Jennens RR; Reck M; Hui R; Garon EB; Boyer M; Rubio-Viqueira B; Novello S; Kurata T; Gray JE; Vida J; Wei Z; Yang J; Raftopoulos H; Pietanza MC; Garassino MC;
    N Engl J Med; 2018 May; 378(22):2078-2092. PubMed ID: 29658856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gefitinib ('Iressa', ZD1839) is active against brain metastases in a 77 year old patient.
    Roggero E; Busi G; Palumbo A; Pedrazzini A
    J Neurooncol; 2005 Feb; 71(3):277-80. PubMed ID: 15735917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Brain metastases of non small cell lung cancers: systemic treatments].
    Chaubet-Houdu M; Besse B
    Bull Cancer; 2013 Jan; 100(1):95-8. PubMed ID: 23376611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.